Actualizado 23/05/2008 11:38
- Comunicado -

New Evidence Advocates the use of Enbrel to Combat and Effectively Control the Debilitating Symptoms of Psoriasis (y 2)

Wyeth is one of the world's largest research-based pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of prescription drugs and over-the-counter medications. It is also a global leader in vaccines, biotechnology and animal health care.

Please ensure that you go to www.wyeth.eu website and register to enable you to view information and updates on the latest Wyeth news and get access to supporting materials to help keep you up-to-date with comprehensive information about Wyeth and our therapy areas.

If you subscribe to receive our emails you will get updates as soon as new content added to the site. Note you will be able to unsubscribe at any time and we will not pass your details to any third party.

References

For full details of references, please contact Karen Crum at OgilvyHealthPR (Direct Tel: +44(0)207-108-6411 / Email: karen.crum@ohpr.co.uk)

Wyeth: Gill Markham, Communications - Europe, Middle East and Africa, Direct Tel: +44(0)1628-692536, Email: markhagl@wyeth.com; Danielle Halstrom, Communications - Global, Tel: +1-484-865-2020, Email: halstrd@wyeth.com; OgilvyHealthPR:, Karen Crum, Direct Tel: +44(0)207-108-6411, Email: karen.crum@ohpr.com; Jodi Lewis, Direct Tel: +44(0)207-108-6086, Email: jodi.lewis@ohpr.com

Comunicados

Si quieres mejorar el posicionamiento online de tu marca, ahora puedes publicar tus notas de prensa o comunicados de empresa en la sección de Comunicados de europa press

Si necesitas asesoramiento en comunicación, redacción de tus notas de prensa o ampliar la difusión de tu comunicado más allá de la página web de europa press, ponte en contacto con nosotros en comunicacion@europapress.es o en el teléfono 913592600